<p>AdaptHealth Corp.（纳斯达克代码：AHCO - 获取免费报告）周一的午盘交易中，股价下跌了 5.5%。该股最低交易价为 9.90 美元，最后交易价为 9.92 美元。午盘交易中大约交易了 454,654 股，较日均交易量 1,044,496 股下降了 56%。该股此前收盘价为 10.50 美元。</p>
<h2>分析师评级调整</h2>
<ul>
<li>3 只小型股领军者有望实现显著增长</li>
</ul>
<p>另外，加拿大皇家银行在 8 月 12 日的研究报告中重申了对 AdaptHealth 的 “跑赢大盘” 评级，并给出了 13.00 美元的目标价。一位研究分析师对该股给予了卖出评级，一位给予了持有评级，三位给予了买入评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价为 10.70 美元。</p>
<p><strong>查看我们对 AHCO 的最新股票分析</strong></p>
<h2>AdaptHealth 股价下跌 3.3%</h2>
<p>该公司的流动比率为 1.15，速动比率为 0.94，债务与股本比率为 1.38。该股的 50 日移动平均价格为 10.80 美元，200 日移动平均价格为 10.44 美元。该公司的市值为 13.6 亿美元，市盈率为-2.01，市盈增长比率为 1.60，贝塔系数为 1.11。</p>
<p>AdaptHealth（纳斯达克代码：AHCO - 获取免费报告）最近一次发布季度财报是在 8 月 6 日。该公司报告本季度每股收益（EPS）为 0.13 美元，低于市场共识预期的 0.19 美元（差额为 0.06 美元）。AdaptHealth 的净利润率为-21.20%，股本回报率为 9.58%。该公司本季度的收入为 8.0598 亿美元，而分析师预期为 8.0262 亿美元。去年同期，该公司每股收益为 0.16 美元。该公司的季度收入同比增长了 1.6%。股票研究分析师预测，AdaptHealth Corp.本年度将发布 0.87 美元的每股收益。</p>
<h2>内部人士下注</h2>
<p>在其他 AdaptHealth 的新闻中，董事 David Solomon Williams III 在 8 月 29 日的交易中出售了 4,000 股该股票。股票以平均价格 11.26 美元出售，总交易额为 45,040.00 美元。交易完成后，该董事现在持有 36,899 股公司股票，价值 415,482.74 美元。这代表其持股比例下降了 0.00%。该交易在向 SEC 的备案中披露，相关信息可在 SEC 网站上找到。在其他 AdaptHealth 的新闻中，首席运营官 Shaw Rietkerk 在 9 月 20 日的交易中出售了 25,000 股该股票。该股票以平均价格 11.24 美元出售，总价值为 281,000.00 美元。交易完成后，首席运营官现在持有 212,611 股公司股票，价值约为 2,389,747.64 美元。该交易代表其持股比例下降了 0.00%。该交易在向 SEC 的备案中披露，相关信息可在 SEC 网站上找到。此外，董事 David Solomon Williams III 在 8 月 29 日的交易中再次出售了 4,000 股公司股票。股票以平均价格 11.26 美元出售，总价值为 45,040.00 美元。交易完成后，该董事现在持有 36,899 股公司股票，价值约为 415,482.74 美元。这代表其持股比例下降了 0.00%。该交易的披露信息可在此处找到。内部人士持有公司 4.43% 的股份。</p>
<h2>机构资金流入和流出</h2>
<p>最近，一些对冲基金增加或减少了对 AHCO 的持股。Covestor Ltd 在第一季度将其在 AdaptHealth 的持股增加了 279.6%。Covestor Ltd 现在持有 3,109 股公司股票，价值 36,000 美元，此前在该期间内又增持了 2,290 股。加拿大养老金计划投资委员会在第二季度购买了 AdaptHealth 的新头寸，价值 58,000 美元。Blue Trust Inc.在第二季度购买了 AdaptHealth 的新头寸，价值 85,000 美元。Innealta Capital LLC 在第二季度购买了 AdaptHealth 的新头寸，价值 101,000 美元。最后，Quest Partners LLC 在第二季度将其在 AdaptHealth 的持股增加了 11,522.7%。Quest Partners LLC 现在持有 10,228 股公司股票，价值 102,000 美元，此前在该期间内又增持了 10,140 股。82.67% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>关于 AdaptHealth</h2>
<p>（获取免费报告）</p>
<p>AdaptHealth Corp.及其子公司在美国销售家庭医疗设备（HME）、医疗用品以及家庭和相关服务。该公司提供睡眠治疗设备、用品及相关服务，如为患有阻塞性睡眠呼吸暂停的个人提供 CPAP 和 bi-PAP 服务；医疗设备和用品，包括用于糖尿病治疗的连续血糖监测仪和胰岛素泵；向从急性护理和其他设施出院的患者提供 HME；在家中提供氧气和相关慢性治疗服务；以及代表慢性病患者提供的其他 HME 设备和用品，包括伤口护理、泌尿、失禁、造口和营养供应需求。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 AdaptHealth</li>
<li>3 只可以帮助应对通货膨胀的食品杂货股票</li>
<li>英特尔：现在是勇敢出手的时候吗？</li>
<li>如何投资蓝筹股</li>
<li>嘉年华还是皇家加勒比——哪只邮轮股票更具上涨潜力？</li>
<li>零售投资者如何交易多伦多证券交易所（TSX）？</li>
<li>Summit Therapeutics：他们的肺癌药物是游戏规则改变者吗？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<p>→ DeFi Coin 即将突破！(来自 Crypto 101 Media)(广告)</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMyOA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMyOA"/></p>
<h2>你现在应该投资$1,000 在 AdaptHealth 吗？</h2>
<p>在考虑 AdaptHealth 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 AdaptHealth 并不在名单上。</p>
<p>虽然 AdaptHealth 目前在分析师中被评为 “持有”，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AHCO

<p>AdaptHealth Corp.（纳斯达克代码：AHCO）股价在午盘交易中下跌了 5.5%，至 0.92 美元，交易量较平均水平下降了 56%。该公司报告的季度每股收益（EPS）为 0.13 美元，未达到预期，净利润率为负 21.20%。分析师维持 “持有” 的共识评级，平均目标价为 0.70 美元。近期内部人士的交易包括董事 David Solomon Williams III 出售了 4,000 股，首席运营官 Shaw Rietkerk 出售了 25,000 股。对冲基金持有该股票的 82.67%，显示出显著的机构投资兴趣</p>

<p>AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report)'s stock price dropped 5.5% during mid-day trading on Monday . The stock traded as low as $9.90 and last traded at $9.92. Approximately 454,654 shares were traded during mid-day trading, a decline of 56% from the average daily volume of 1,044,496 shares. The stock had previously closed at $10.50.</p>
<div class="lb-trans"><p>AdaptHealth Corp.（纳斯达克代码：AHCO - 获取免费报告）周一的午盘交易中，股价下跌了 5.5%。该股最低交易价为 9.90 美元，最后交易价为 9.92 美元。午盘交易中大约交易了 454,654 股，较日均交易量 1,044,496 股下降了 56%。该股此前收盘价为 10.50 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><ul>
<li>3 Small-Cap Leaders Poised for Significant Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只小型股领军者有望实现显著增长</li>
</ul>
</div><p>Separately, Royal Bank of Canada reissued an &#34;outperform&#34; rating and issued a $13.00 target price on shares of AdaptHealth in a research note on Monday, August 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Hold&#34; and an average target price of $10.70.</p>
<div class="lb-trans"><p>另外，加拿大皇家银行在 8 月 12 日的研究报告中重申了对 AdaptHealth 的 “跑赢大盘” 评级，并给出了 13.00 美元的目标价。一位研究分析师对该股给予了卖出评级，一位给予了持有评级，三位给予了买入评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价为 10.70 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on AHCO</strong></p>
<div class="lb-trans"><p><strong>查看我们对 AHCO 的最新股票分析</strong></p>
</div><h2>AdaptHealth Trading Down 3.3 %</h2>
<div class="lb-trans"><h2>AdaptHealth 股价下跌 3.3%</h2>
</div><p>The company has a current ratio of 1.15, a quick ratio of 0.94 and a debt-to-equity ratio of 1.38. The stock's fifty day moving average price is $10.80 and its two-hundred day moving average price is $10.44. The stock has a market capitalization of $1.36 billion, a P/E ratio of -2.01, a price-to-earnings-growth ratio of 1.60 and a beta of 1.11.</p>
<div class="lb-trans"><p>该公司的流动比率为 1.15，速动比率为 0.94，债务与股本比率为 1.38。该股的 50 日移动平均价格为 10.80 美元，200 日移动平均价格为 10.44 美元。该公司的市值为 13.6 亿美元，市盈率为-2.01，市盈增长比率为 1.60，贝塔系数为 1.11。</p>
</div><p>AdaptHealth (NASDAQ:AHCO - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. The business had revenue of $805.98 million for the quarter, compared to analysts' expectations of $802.62 million. During the same quarter in the previous year, the company earned $0.16 earnings per share. The business's quarterly revenue was up 1.6% on a year-over-year basis. Equities research analysts forecast that AdaptHealth Corp. will post 0.87 EPS for the current year.</p>
<div class="lb-trans"><p>AdaptHealth（纳斯达克代码：AHCO - 获取免费报告）最近一次发布季度财报是在 8 月 6 日。该公司报告本季度每股收益（EPS）为 0.13 美元，低于市场共识预期的 0.19 美元（差额为 0.06 美元）。AdaptHealth 的净利润率为-21.20%，股本回报率为 9.58%。该公司本季度的收入为 8.0598 亿美元，而分析师预期为 8.0262 亿美元。去年同期，该公司每股收益为 0.16 美元。该公司的季度收入同比增长了 1.6%。股票研究分析师预测，AdaptHealth Corp.本年度将发布 0.87 美元的每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other AdaptHealth news, Director David Solomon Williams III sold 4,000 shares of the stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total transaction of $45,040.00. Following the completion of the sale, the director now owns 36,899 shares of the company's stock, valued at $415,482.74. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other AdaptHealth news, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total value of $281,000.00. Following the completion of the sale, the chief operating officer now owns 212,611 shares in the company, valued at approximately $2,389,747.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director David Solomon Williams III sold 4,000 shares of the company's stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total value of $45,040.00. Following the transaction, the director now owns 36,899 shares of the company's stock, valued at approximately $415,482.74. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.43% of the company's stock.</p>
<div class="lb-trans"><p>在其他 AdaptHealth 的新闻中，董事 David Solomon Williams III 在 8 月 29 日的交易中出售了 4,000 股该股票。股票以平均价格 11.26 美元出售，总交易额为 45,040.00 美元。交易完成后，该董事现在持有 36,899 股公司股票，价值 415,482.74 美元。这代表其持股比例下降了 0.00%。该交易在向 SEC 的备案中披露，相关信息可在 SEC 网站上找到。在其他 AdaptHealth 的新闻中，首席运营官 Shaw Rietkerk 在 9 月 20 日的交易中出售了 25,000 股该股票。该股票以平均价格 11.24 美元出售，总价值为 281,000.00 美元。交易完成后，首席运营官现在持有 212,611 股公司股票，价值约为 2,389,747.64 美元。该交易代表其持股比例下降了 0.00%。该交易在向 SEC 的备案中披露，相关信息可在 SEC 网站上找到。此外，董事 David Solomon Williams III 在 8 月 29 日的交易中再次出售了 4,000 股公司股票。股票以平均价格 11.26 美元出售，总价值为 45,040.00 美元。交易完成后，该董事现在持有 36,899 股公司股票，价值约为 415,482.74 美元。这代表其持股比例下降了 0.00%。该交易的披露信息可在此处找到。内部人士持有公司 4.43% 的股份。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds have recently added to or reduced their stakes in AHCO. Covestor Ltd grew its holdings in shares of AdaptHealth by 279.6% during the 1st quarter. Covestor Ltd now owns 3,109 shares of the company's stock worth $36,000 after acquiring an additional 2,290 shares during the period. Canada Pension Plan Investment Board bought a new position in AdaptHealth in the second quarter worth $58,000. Blue Trust Inc. purchased a new position in AdaptHealth during the second quarter valued at $85,000. Innealta Capital LLC purchased a new position in AdaptHealth during the second quarter valued at $101,000. Finally, Quest Partners LLC grew its position in shares of AdaptHealth by 11,522.7% in the 2nd quarter. Quest Partners LLC now owns 10,228 shares of the company's stock worth $102,000 after buying an additional 10,140 shares during the period. 82.67% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>最近，一些对冲基金增加或减少了对 AHCO 的持股。Covestor Ltd 在第一季度将其在 AdaptHealth 的持股增加了 279.6%。Covestor Ltd 现在持有 3,109 股公司股票，价值 36,000 美元，此前在该期间内又增持了 2,290 股。加拿大养老金计划投资委员会在第二季度购买了 AdaptHealth 的新头寸，价值 58,000 美元。Blue Trust Inc.在第二季度购买了 AdaptHealth 的新头寸，价值 85,000 美元。Innealta Capital LLC 在第二季度购买了 AdaptHealth 的新头寸，价值 101,000 美元。最后，Quest Partners LLC 在第二季度将其在 AdaptHealth 的持股增加了 11,522.7%。Quest Partners LLC 现在持有 10,228 股公司股票，价值 102,000 美元，此前在该期间内又增持了 10,140 股。82.67% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>About AdaptHealth</h2>
<div class="lb-trans"><h2>关于 AdaptHealth</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.</p>
<div class="lb-trans"><p>AdaptHealth Corp.及其子公司在美国销售家庭医疗设备（HME）、医疗用品以及家庭和相关服务。该公司提供睡眠治疗设备、用品及相关服务，如为患有阻塞性睡眠呼吸暂停的个人提供 CPAP 和 bi-PAP 服务；医疗设备和用品，包括用于糖尿病治疗的连续血糖监测仪和胰岛素泵；向从急性护理和其他设施出院的患者提供 HME；在家中提供氧气和相关慢性治疗服务；以及代表慢性病患者提供的其他 HME 设备和用品，包括伤口护理、泌尿、失禁、造口和营养供应需求。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than AdaptHealth</li>
<li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation</li>
<li>Intel: Is Now the Time to Be Brave?</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?</li>
<li>How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?</li>
<li>Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 AdaptHealth</li>
<li>3 只可以帮助应对通货膨胀的食品杂货股票</li>
<li>英特尔：现在是勇敢出手的时候吗？</li>
<li>如何投资蓝筹股</li>
<li>嘉年华还是皇家加勒比——哪只邮轮股票更具上涨潜力？</li>
<li>零售投资者如何交易多伦多证券交易所（TSX）？</li>
<li>Summit Therapeutics：他们的肺癌药物是游戏规则改变者吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><p>→ DeFi Coin on Verge of Breakout! (From Crypto 101 Media)(Ad)</p>
<div class="lb-trans"><p>→ DeFi Coin 即将突破！(来自 Crypto 101 Media)(广告)</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMyOA" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10328&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in AdaptHealth right now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 AdaptHealth 吗？</h2>
</div><p>Before you consider AdaptHealth, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 AdaptHealth 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 AdaptHealth 并不在名单上。</p>
</div><p>While AdaptHealth currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 AdaptHealth 目前在分析师中被评为 “持有”，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

AdaptHealth（纳斯达克股票代码：AHCO）股价下跌 5.5% - 事情是这样的